This preview shows page 1-2-3-4-5 out of 15 pages.

Save
View full document
View full document
Premium Document
Do you want full access? Go Premium and unlock all 15 pages.
Access to all documents
Download any document
Ad free experience
View full document
Premium Document
Do you want full access? Go Premium and unlock all 15 pages.
Access to all documents
Download any document
Ad free experience
View full document
Premium Document
Do you want full access? Go Premium and unlock all 15 pages.
Access to all documents
Download any document
Ad free experience
View full document
Premium Document
Do you want full access? Go Premium and unlock all 15 pages.
Access to all documents
Download any document
Ad free experience
View full document
Premium Document
Do you want full access? Go Premium and unlock all 15 pages.
Access to all documents
Download any document
Ad free experience
Premium Document
Do you want full access? Go Premium and unlock all 15 pages.
Access to all documents
Download any document
Ad free experience

Unformatted text preview:

161718192021Role of citric acid cycle in anabolismAnaplerotic rxns (in red) replenish depleted cycle intermediates22Feeder pathways for glycolysis hexosecatabolismGal(β1->4) Glclivermusclestorage polysaccharidesGlc(α1<->α4) GlcFr(β2<->α1) GlcGlc(α1->4) Glc23Glycogen granules associate with the smooth endoplasmic reticulum in the cytoplasmSmooth ERRough ERMitoGlycogen GranulesGlycogen makes up 7-10% wet weight of liver and 1-2% wet weight of a muscle cell. Equivalent concentration of glucose is 0.4 M but because it is a polymer and insoluble, it actually contributes to a concentration of 0.1 microM in the cell. Glycogen is stored in large cytoplasmic granules in the cell, associated with the smooth endoplasmic reticulum. The glycogen particle has a higher order structure. The Beta-particle is 21 nm in diameter and consists of 55,000 glucose residues with about 2,000 non-reducing ends. 20 to 40 particules cluster together to form an alpha-rosette, which is seen in the electron micrograph of a well-fed animal hepatocyte (liver cell). After a 24 hour fast, essentially no glycogen particles will be detected. The glycogen is organized with the enzymes that catalyze synthesis and degradation as a mini-factory within the cells. The enzymes that work on glycogen are NOT floating freely throughout the cell!24Glycogen structureStorage polysaccharideα1->4 polymer of glucose with α1->6 branchesmore extensively branched than starch and more compactstored in liver, muscle ave MW 7 million25Glycogen BreakdownGlucose mobilized from nonreducing endphosphorolysis reaction G-1-P (P maintains energy)Glu-6-PGlycogen phosphorylase catalyzes phosphorolytic cleavage of the alpha (1Æ4) glycosidic linkages of glycogen, releasing glucose-1-P as a reaction productGlycogen (n residues) +Pi Æ glycogen (n-1) + glucose-1-PPhophorolysis may be compared to hydrolysis:Hydrolysis R-O-R’ + HOH Æ R-OH and R’-OHPhosphorolysis: R-O-R’ + HO-PO3 2- Æ R-OH + R’-O-PO3 2-Glycogen Phosphorylase has Pyridoxal Phosphate (PLP), a derivative of Vit B6 as a prosthetic group.PLP is held at the active site of the phosphorylase enzyme by a Schiff base linkage, formed by reaction of the aldehyde of PLP with the epsilon amino group of a lysine residueIn contrast to the role of this cofactor in other enzymes, the phosphate of PLP is involved in acid/base catalysis by Phosphorylase. The Pi substrate binds between the phosphate of PLP and the glycosidic O linking the terminal glucose residue of the glycogen. After the phosphate substrate donates H+ during cleavage of the glycosidic bond, it receives H+ from the phosphate moiety of PLP.PLP then takes back the H+ as the phosphate O attacks C1 of the cleaved glucose to yield glucose-1-phosphate26A glucose analog, N-acetylglucosamine (GlcNAc), is adjacent to pyridoxal phosphate at the active site in the crystal structure shown. Glycogen Phosphorylase:A homodimericenzyme, subject to allosteric control. Crystal structure: PLP PLP GlcNAc GlcNAc inhibitor Human Liver Glycogen Phosphorylase PDB 1EM627Question: Why would an inhibitor of Glycogen Phosphorylase be a suitable treatment for diabetes?A class of drugs developed for treating the hyperglycemia of diabetes (chloroindole-carboxamides), inhibit liver Phosphorylase allosterically.These inhibitors bind at the dimer interface, stabilizing the inactive conformation. PLP PLP GlcNAc GlcNAc inhibitor Human Liver Glycogen Phosphorylase PDB 1EM6 A glycogen storage site on the surface of the Phosphorylase enzyme binds the glycogen particle. Given the distance between the storage and active sites, Phosphorylase can \ cleave alpha (1Æ4) linkages only to within 4 residues of an alpha (1Æ6) branch point. This is called the limit branch.28cleaves until 4 glucoses from a branch point debranching enzyme -2 functions1. transferase activity2. α1->6 glucosidasePhosphorylase can act again until 4 glucoses from a branch pointhydrolysis rxnDebranching enzyme has 2 independent active sites consisting of residues indifferent segments of a single polypeptide chain.The transferase of the debranching enzyme transfers 3 glucose residues from a 4-residue limit branch to the end of another branch, diminishing the limit branch to a single glucose residue.The alpha (1Æ6) glucosidase moiety of the debranching enzyme then catalyzes hydrolysis of the alpha (1Æ6) linkage, yielding free glucose. This is a minor fraction of the glucose released from glycogen.The major product then of glycogen breakdown is glucose-1-phosphate, from phosphorylase activitiy.29Glc-1-P to Glc-6-P and then glycolysis, mxn of phosphoglucomutase:reversible reactionmxn similar to phosphoglyceromutase(except E-His)G-6-P in liver to glycolysis or pentose P pathway or to other tissues. Serine is phosphorylated and de-phosphorylatedin the catalytic cyclePhosphoglucomutase catalyzes the reversible reaction:Glucose 1-P Å> glucose -6-PA serine OH at the active site donates and accepts Pi. The bisphosphate is not rreleased. Phosphoglycerate mutase has a similar mechanism, but instead uses His for Pi transferThe product glucose-6-p may enter glycolysis or (in liver) be dephosphorylated for release to the blood.30 Glycogen Glucose Hexokinase or Glucokinase Glucose-6-Pase Glucose-1-P Glucose-6-P Glucose + Pi Glycolysis Pathway Pyruvate Glucose metabolism in liver. To bloodRole in maintainingBlood [glucose] steady(from blood, i.e. after eating)phosphoglucomutaseThe reversible phosphoglucomutase may also convert glucose-6-P Æglucose -1-P, precursor for glycogen synthesis as well as glycogen breakdown product. Liver glucose-6-P catalyzes the following , essential to the liver’s role in maintaining blood glucose:Glucose-6-P + H2O Æ glucose + PiMost other tissues lack this


View Full Document

UCLA CHEM 153C - L1p16-30

Download L1p16-30
Our administrator received your request to download this document. We will send you the file to your email shortly.
Loading Unlocking...
Login

Join to view L1p16-30 and access 3M+ class-specific study document.

or
We will never post anything without your permission.
Don't have an account?
Sign Up

Join to view L1p16-30 2 2 and access 3M+ class-specific study document.

or

By creating an account you agree to our Privacy Policy and Terms Of Use

Already a member?